A new laboratory study provides evidence about how advanced age can be protective against cancer — with implications for treating patients in different age groups.

Fructose consumption has increased considerably over the past five decades, largely due to the widespread use of high-fructose corn syrup as a sweetener in beverages and ultra-processed foods. New research from Washington University in St. Louis shows that dietary fructose promotes tumor growth in animal models of melanoma, breast cancer and cervical cancer. However, fructose does not directly fuel tumors, according to the study published Dec. 4 in the journal Nature. Instead, WashU scientists discovered that the liver converts fructose into usable nutrients for cancer cells, a compelling finding that could open up new avenues for care and treatment of many different types of cancer.

Researchers at NYU Abu Dhabi (NYUAD) have developed an innovative cationic covalent organic framework (COF) that efficiently detects and removes perfluorooctanoic acid (PFOA), a harmful and persistent pollutant, from drinking water. This breakthrough addresses a global challenge of removing perfluorinated alkylated substances (PFAS), or “forever chemicals”, which raised environmental and health concerns due to their accumulation in water and links to severe health risks, including cancer and developmental issues. 

BUFFALO, NY – December 4, 2024 – A new editorial was published in Oncotarget’s Volume 15 on November 22, 2024, entitled “B7-H4: A potential therapeutic target in adenoid cystic carcinoma.” 

Lung cancer is emerging as a public health crisis. Yet, there is limited information on the lifetime risk of developing and dying from lung cancer at global, regional, and national levels. To bridge this gap, researchers from China estimated the lifetime risk of lung cancer across 185 countries in 2022. Their findings reveal the diverse impact of lung cancer across countries, sexes, and age groups, highlighting the need for more targeted interventions.

Researchers have developed a three-step plan to support those burdened by the intense fear of cancer returning. This plan offers a consistent, streamlined approach to managing recurrence anxiety, empowering patients to regain confidence and move forward with their lives.

In a paper published in MedComm, an international team of scientists combined principles of bioengineering, biocoupling, and micro–nanotechnology to introduce a subclassification system based on these design principles and provide an in-depth discussion on the current status of clinical transformation of micro- and nanostructured systems inspired by plants, microorganisms, and animals, as well as the encountered challenges during this process for the first time. This work will establish a robust theoretical framework and serve as a valuable reference to facilitate advancements in research and clinical application within this field.

Today, women with oestrogen-sensitive breast cancer receive anti-hormonal therapy. Researchers now show that postmenopausal women with low-risk tumours have a long-term benefit for at least 20 years, while the benefit was more short-term for younger women with similar tumour characteristics who had not yet gone through the menopause. The results are reported in the Journal of the National Cancer Institute (JNCI).